Overview
News
Salaries
Products
People
Growth
Offices
Financials

Overview

Pulmonx has developed the Zephyr Endobronchial Valve Therapy, a minimally invasive treatment for emphysema, a form of COPD.

News

News YahooFinance 27 days ago
Pulmonx Corporation Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
REDWOOD CITY, Calif., Sept. 01, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (the
Read more
Report
Press release The Manila Times 5 months ago
Pulmonx Reports First Quarter 2026 Financial Results
REDWOOD CITY, Calif., April 29, 2026 (GLOBE NEWSWIRE) -- Pulmonx Corporation (Nasdaq: LUNG) (
Read more
Report
Press release The Globe and Mail 5 months ago
Pulmonx Reports First Quarter 2026 Financial Results
Detailed price information for Pulmonx Corp (LUNG-Q) from The Globe and Mail including charting and trades.
Read more
Report
Pulmonx Stock Pops on Takeover Deal: Cash Exit or Hold Out?
Pulmonx just stunned Wall Street with an all-cash takeover agreement. The premium is real-but is there still upside left for US investors, or is it time to lock in gains and move on?
Read more
Report
Pro access
Upgrade to see all 8 mentions
Upgrade to a paid plan to read every media mention of this company - funding news, awards, product launches and press releases from all the outlets writing about it.
Every media mention and press release
Funding news, awards and product launches
Fresh coverage from every outlet writing about the company
Upgrade now
Cancel anytime. Secure checkout. Instant activation.

People

Glendon French
Executive Officer, Director
Lauren Cristina
Executive Officer
Dana Mead Jr
Director
Stephen Salmon
Director
Rodney Perkins M.d.
Director
Oern Stuge
Director
Michael Matly
Director
Staffan Lindstrand
Director
Rich Ferrari
Director
Charles Chon
Director
Names and roles come from public filings, company registers and the company's own site. Is this you? Correct or remove · How we handle this data

Offices

Where the company hires and what each office is for
Cities
1
Hiring now
0
Countries
1
Redwood City United States
HQ
200-500 est. staff

Financials

Total raised
$115.1M
Latest round
Venture - Series Unknown
Funding rounds
2
Funding rounds
Round Announced Amount
Venture - Series Unknown 2019 $65.1M Details
Venture - Series Unknown 2015 $50M Details